Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of FUBP1 inhibitors for treating hepatitis B virus infection

Use of FUBP1 inhibitors for treating hepatitis B virus infection

US Patent 11732262 · Granted Aug 22, 2023

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Oligonucleotides for modulating RTEL1 expression2025
Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatit2025
Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatit2025
Oligonucleotides for inducing paternal UBE3A expression2025
Oligonucleotides for modulating SCN9A expression2024
Enhanced oligonucleotides for inhibiting RTEL1 expression2024
Enhanced oligonucleotides for inhibiting RTEL1 expression2024
Oligonucleotides for inducing paternal UBE3A expression2023
Inhibitor for use for preventing and/or treating an infection with hepatitis B v2023
Inhibitor for use for preventing and/or treating an infection with hepatitis B v2023
Antisense oligonucleotides targeting ATXN32023
Nucleic acid molecules for reduction of PAPD5 or PAPD7 mRNA for treating hepatit2022